AzTrials
AzTrials

DepressionPATHwayNCT05203198

The PATHway Study: Primary Care Based Depression Prevention in Adolescents

A study testing Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training in people with Depression and Mental Disorder in Adolescence, run by University of Illinois Chicago at 6 sites in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Prevention of depressive disorders has become a key priority for the NIMH, but the investigators have no widely available public health strategy to reduce morbidity and mortality. Read more about this study

Who is it for?
Ages 13 to 18 yearsHealthy volunteers can take part
Conditions the study is for
Depression, Mental Disorder in Adolescence
What is being tested?
Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
400 participants
Where
6 sitesUnited States
Study dates
1 Feb 2022to 31 Oct 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 to 18 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Adolescents ages 13 through 18 years, and
  • Adolescents must be experiencing an elevated level of depressive symptoms (PHQ-9 = 5-18), and
  • Adolescents will be included if they have had past depressive episode/s, but not if they are in a current depressive episode.

Who cannot join

  • Outside age range:
  • 12 or younger
  • 19 or older
  • Adolescent is a non-English speaker/reader
  • On the PHQ-9 screening, depression symptom level is:
  • PHQ-9 = 4 or lower
Show all 27Show fewer
  • PHQ-9 =19 or higher
  • As assessed by the MINI Kid, a current depressive episode
  • As assessed by the MINI Kid, adolescent meets DSM-5 criteria for a psychotic or bipolar disorder.
  • Currently using medication therapy for depression, anxiety, or other internalizing disorders.
  • Currently engaged in individual treatment for a mood disorder (assessed by BCC during phone screen)
  • Currently engaged in a cognitive-behavioral group or therapy (assessed by BCC during phone screen)
  • Any past psychiatric hospitalizations
  • Any past suicide attempt or incident of self-harm with moderate or greater lethality
  • Extreme, current drug/alcohol abuse (determined by clinician follow up following a score of 3 or greater on the CRAFFT)
  • Current suicidal thoughts
  • Eligibility will be determined on a case-by-case basis during the baseline PhQ-9 and MINI Kid assessment process and after a consultation with a licensed mental health clinician has taken place. If adolescent report suicidal ideation on the baseline PhQ-9, and found ineligible, the MINI Kid assessment may not be required.
  • Adolescents with current (within the past 6 months), active suicidal feelings will be excluded.
  • Adolescents with passive thoughts of death or suicide but report to the mental health clinician that they would never act on these thoughts may be admitted, depending on the severity of the risk.
  • Adolescents with past (greater than 6 months ago) ideation who are determined to be low risk will be admitted into the study if there has never been an attempt of moderate or greater lethality.
  • Significant reading impairment (a minimum sixth-grade reading level based on parental report) and/or significant intellectual or developmental disabilities
  • Not willing to comply with the study protocol
  • Did not complete phone assessment with MINI Kid by BCC
  • Not affiliated with any of the sites listed in Appendix A.
  • Parent/guardian does not speak English or Spanish
  • Parent/guardian has a cognitive or intellectual impairment
  • Participant Declined/Changed Mind/Uninterested in participating

Trial locations and contacts

6 sites in 1 country.

6 sites in 1 country

United States6 sites
  • Ann & Robert H. Lurie Children's Hospital of Chicago

    Chicago, Illinois, 60611

  • UI Health

    Chicago, Illinois, 60612

  • University of Chicago Comer Children's Hospital

    Chicago, Illinois, 60637

  • UT Southwestern Medical Center

    Dallas, Texas, 75390

  • Northshore University HealthSystem

    Glenview, Illinois, 60026

  • Advocate Aurora Health

    Park Ridge, Illinois, 60068

Other trials in United States

About this study

Official title: Primary Care Based Depression Prevention in Adolescents: Intervention Optimization in Preparation for Implementation Study

Prevention of depressive disorders has become a key priority for the NIMH, but the investigators have no widely available public health strategy to reduce morbidity and mortality. To address this need, the investigators developed and evaluated the primary care based-technology "behavioral vaccine," Competent Adulthood Transition with Cognitive-Behavioral Humanistic and Interpersonal Therapy (CATCH-IT). The investigators will engage N=4 health systems representative of the United States health care system, and conduct a factorial design study to optimize the intervention in preparation for an implementation study and eventual dissemination.

Read the detailed description

With more than 13% of adolescents diagnosed with depressive disorders each year, prevention of depressive disorders has become a key priority for the National Institute of Mental Health (NIMH). Unfortunately, the investigators have no widely available interventions to reduce morbidity and mortality (e.g. public health impact). To address this need, the investigators developed a multi-health system "collaboratory" to develop and evaluate the primary care based technology "behavioral vaccine," Competent Adulthood Transition with Cognitive-Behavioral Humanistic and Interpersonal Therapy (CATCH-IT) (14 adolescent, 5 parent modules). Using this health-system collaboratory model, the full CATCH-IT program (all modules), demonstrated evidence of efficacy in prevention of depressive episodes in phase-three clinical trials in the United States and China. However, like many "package" interventions, CATCH-IT became larger and more complex across efficacy trials. Thus, adolescents were less willing to complete all 14 modules, suggesting adolescent dose "tolerability" issues (e.g., satisfaction, acceptability and resource use, "time as cost"). Similarly, primary care practices have "scalability" challenges (acceptability, feasibility, resource use, cost), resulting in declining REACH (percent of at-risk youth who complete intervention). To prepare for implementation studies and dissemination, the investigators need to address adolescent tolerability and practice/health system scalability, while preserving efficacy. Multiphase Optimization Strategy (MOST) uses a systematic analytic approach and a factorial randomized clinical trial design to address efficacy, tolerability, and scalability, simultaneously. The investigators will use a MOST approach to optimize CATCH-IT for the prevention of depression (indicated prevention, i.e., elevated symptoms of depression) in practices and health systems representative of US geography and population. The theoretically grounded components of CATCH-IT selected for study and optimization include: behavioral activation, cognitive-behavioral therapy, interpersonal psychotherapy, and parent program. The investigators will use a 4-factor (2x2x2x2) fully crossed factorial design with N=16 cells (25 per cell, 15% dropout) to evaluate the contribution of each component. The investigators propose to randomize N=400 adolescents from multiple sites: Advocate-Aurora Health Care (n=200); Lurie Children's Hospital (n=70); NorthShore University HealthSystem (n=70); University of Chicago Comer Hospital (n=25); University of Texas (n=20); University of Illinois College of Medicine Peoria (n=15). The at-risk youth will be high school students 13 through 18 years old, not currently experiencing a mood disorder, but with subsyndromal symptoms of depression (moderate to high risk). Using the efficient factorial design, the investigators can assess the contribution to prevention efficacy of each component. Thus, the MOST study design will enable us to eliminate non-contributing components while preserving efficacy and to optimize CATCH-IT by strengthening tolerability and scalability by reducing "resource use." By reducing resource use, the investigators anticipate satisfaction and acceptability will also increase, preparing the way for an implementation trial and eventual US Preventive Services Task Force endorsement to support dissemination. Thus, the primary question is whether one component, or perhaps two, can demonstrate an equivalent effect to combinations of other components in terms of efficacy, whilst also demonstrating superior adolescent/family tolerability scalability over a 12-month follow-up.

Being tested
Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training
Keywords
Adolescents Depression, Internet intervention, Cognitive-Behavioral Therapy, Prevention, MOST design
Medical subject headings
Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal TrainingBehavioural

    Also called CATCH-IT

    Self-directed, technology-based, depression prevention program for adolescents and parents.

Study groups in NCT05203198
Study groupRoleWhat they receive
1. No adolescent modules + no parent modulesNo interventionNo adolescent nor parent modules will be offered to the participant.
2. Adolescent behavioral activation modules onlyExperimentalAdolescent behavioral activation modules only
Receives: Behavioral: Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training
3. Adolescent cognitive-behavioral therapy modules onlyExperimentalAdolescent cognitive-behavioral therapy modules only
Receives: Behavioral: Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training
4. Adolescent interpersonal therapy modules onlyExperimentalAdolescent interpersonal therapy modules only
Receives: Behavioral: Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training
5. Adolescent behavioral activation modules + cognitive-behavioral therapy modulesExperimentalAdolescent behavioral activation modules Adolescent cognitive-behavioral therapy modules
Receives: Behavioral: Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training
6. Adolescent behavioral activation modules + interpersonal therapy modulesExperimentalAdolescent behavioral activation modules Adolescent interpersonal therapy modules
Receives: Behavioral: Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training
7. Adolescent cognitive-behavioral therapy modules + interpersonal therapy modulesExperimentalAdolescent cognitive-behavioral therapy modules Adolescent interpersonal therapy modules
Receives: Behavioral: Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training
8. Full Adolescent program onlyExperimentalAdolescent behavioral activation modules Adolescent cognitive-behavioral therapy modules Adolescent interpersonal therapy modules
Receives: Behavioral: Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training
9. Parent program modules onlyExperimentalParent program modules
Receives: Behavioral: Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training
10. Adolescent behavioral activation modules + parent program modulesExperimentalAdolescent behavioral activation modules Parent program modules
Receives: Behavioral: Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training
11. Adolescent cognitive-behavioral therapy modules + parent program modulesExperimentalAdolescent cognitive-behavioral therapy modules Parent program modules
Receives: Behavioral: Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training
12. Adolescent interpersonal therapy modules + parent program modulesExperimentalAdolescent interpersonal therapy modules Parent Program
Receives: Behavioral: Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training
13. Adolescent behavioral activation + cognitive-behavioral therapy + parent program modulesExperimentalAdolescent behavioral activation modules Adolescent cognitive-behavioral therapy modules Parent program modules
Receives: Behavioral: Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training
14. Adolescent behavioral activation + interpersonal therapy + parent program modulesExperimentalAdolescent behavioral activation modules Adolescent interpersonal therapy modules Parent program modules
Receives: Behavioral: Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training
15. Adolescent cognitive-behavioral therapy + interpersonal therapy + parent program modulesExperimentalAdolescent cognitive-behavioral therapy modules Adolescent interpersonal therapy modules Parent program modules
Receives: Behavioral: Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training
16. All adolescent + parent program modulesActive comparatorAdolescent behavioral activation modules Adolescent cognitive-behavioral therapy modules Adolescent interpersonal therapy modules Parent program modules
Receives: Behavioral: Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time

    Time will be measured to nearest minute for all intervention related activities including initial screening, engagement phone calls, use of CATCH-IT. Time will be measured from adolescent, family, practice, community center, healthcare organization, health system perspective. For time that cannot be directly measured by study staff, the investigators will sample direct observation or questionnaires to capture time required for health system related activities such as screening and engagement.

    Measured: Baseline through 12 months

  2. Cultural acceptability adolescent and family

    Cultural acceptability for each stakeholder using appropriate, validated instruments. Adolescent and family: Usefulness, Satisfaction, and Ease Questionnaire (USE, 30 items, self-report, 7-point Likert scale, 30-210 score range, higher score indicates more acceptable). An example statement is: "I would recommend this to a friend."

    Measured: Baseline through 12 months

  3. Cost

    Costs will be measured for all stakeholders. For practice, community center, healthcare organizations, health systems, cost will be measured to nearest dollar by converting time measures into employment related costs based on mean wages and benefits for staff at that occupational level. Adolescent and family costs will be measured by converting time into mean hourly wages and benefits for adolescent and family members involved in the project (based on mean wage for age and occupation).

    Measured: Baseline through 12 months

  4. Depressive Symptoms

    Patient Health Questionnaire-Adolescent (PHQ-A, 9 items plus 4 follow-up items, self-report, 3-point Likert scale, 0-27 score range, higher score indicates more depression symptoms/severity).

    Measured: Baseline through 12 months

  5. Depressive and mental disorder episodes

    Mini-International Neuropsychiatric Interview for Children and Adolescents (MINI Kid, self-report). This is a structured psychiatric interview administered by a trained staff member which uses stem questions and follow-ups to determine the presence of symptoms and date of onset. The staff member then determines if and when the symptoms developed an episode is present. Measure is either episode present or not and date of onset.

    Measured: Baseline through 12 months

  6. Stress symptoms

    Center for Epidemiological Studies-Depression Scale (CES-D, 20 items, self-report, measured in frequency, 0,"not at all" to 3, "nearly every day in last week, 0-60 score range, higher score indicates more depressed).

    Measured: Baseline through 12 months

  7. Resiliency

    Resiliency will be measured across multiple domains. To assess resiliency in terms of coping skills, the Connor-Davidson Resilience Scale (CD-RISC, 10 items, self-report, 4 levels of response, 0-40 score range, higher score indicates better coping skills).

    Measured: Baseline through 12 months

  8. Function

    Social Adjustment Scale Self-Report (SAS-SR, 23-items, self-report, 5-point Likert scale, 23-115 score range, higher score indicates higher levels of social adjustment) administered to adolescents only.

    Measured: Baseline through 12 months

  9. Relationships (Life Events)

    University of California at Los Angeles (UCLA) Life Events Scale (19-items, self-report) administered to adolescents only.

    Measured: Baseline through 12 months

  10. Socio-cultural Relevance

    The Socio-Cultural Relevance Scale (10-item and 14-item versions, self-report, 5-point Likert scale, 10-40 or 14-56 score ranges, higher score indicates greater socio-cultural relevance) will assess perceived change and satisfaction with the intervention, component of cultural acceptability to adolescent)

    Measured: Baseline through 12 months

  11. Acceptability of Intervention

    Acceptability of Intervention Measure (AIM, 1 question with 4 items, self-report, 5-point Likert scale, 1-5 score range, higher score indicates greater acceptability of intervention, to be completed by all staff and leadership, repeatedly, component of cultural acceptability to practice, community center, healthcare organizations, health systems).

    Measured: Start to end of recruitment, 32 months

  12. Feasibility of Intervention

    Feasibility of Intervention Measure (FIM, 1 question with 4 items, self-report, 5-point Likert scale, 1-5 score range, higher score indicates greater feasibility of intervention, to be completed by all staff and leadership, repeatedly, component of cultural acceptability to practice, community center, healthcare organizations, health systems).

    Measured: Start to end of recruitment, 32 months

  13. Intervention Appropriateness

    Intervention Appropriateness Measure (IAM, 1 question with 4 items, self-report, 5-point Likert scale, 1-5 score range, higher score indicates greater appropriateness of intervention, to be completed by all staff and leadership, repeatedly, component of cultural acceptability to practice, community center, healthcare organizations, health systems).

    Measured: Start to end of recruitment, 32 months

  14. Externalizing Behavior Symptoms

    Disruptive Behavior Disorders Rating Scale-Adolescent (DBD-A, 41-items, self-report, 4-point Likert scale, 0-123 score range, higher score indicates greater externalizing symptoms).

    Measured: Baseline through 12 months

  15. Anxiety Symptoms

    Screen for Child Anxiety Related Disorders (SCARED, 41-items, self-report, 3-point Likert scale, 0-82 score range, higher score indicates greater anxiety symptoms).

    Measured: Baseline through 12 months

  16. Substance Abuse Symptoms

    Car, Relax, Alone, Forget, Friends, Trouble substance use assessment (CRAFFT, 6 items, self-report, 2-point scale, 0-6 score range, higher score indicates greater substance abuse symptoms).

    Measured: Baseline through 12 months

  17. Post Traumatic Stress Disorder Symptoms

    Child Post Traumatic Symptoms Disorder Scale (24-items, self-report, 4-point Likert scale, 0-72 score range, higher score indicates greater PTSD symptom levels).

    Measured: Baseline through 12 months

  18. Rumination

    Tendency towards rumination will be assessed by the Children's Response Style Scale (CRSS, 10-items, self-report, 5-point Likert scale, 0-50 score range, higher score indicates greater rumination (more repeated negative thinking, less resilient, component of resiliency).

    Measured: Baseline through 12 months

  19. Dysfunctional Attitudes

    The Dysfunctional Attitude Scale (DAS, 9-item, self-report, 7-point Likert scale, 9-63 score range, higher score indicates more dysfunctional attitude, less resiliency, component of resiliency).

    Measured: Baseline through 12 months

  20. Family Relationships

    Child Report of Parental Behavior Inventory (CRPBI, 30-item, self-report, 3-point Likert scale, 0-60 score range, higher scores indicate more positive parent child relationship).

    Measured: Baseline through 12 months

  21. Cognitive Style

    The Children's Cognitive Style Questionnaire (CCSQ, 6-items, self-report, 5-point Likert scale, 0-150 range, higher score indicates greater negativity of cognitive style).

    Measured: Baseline through 12 months

  22. Self-efficacy

    The Trans-Theoretical Model Scale (TTMS, 10-item, self-report, 4-point Likert scale, 0-24 range, higher score indicates higher self-efficacy and intention to reduce depressive symptoms).

    Measured: Baseline through 12 months

  23. Social Adjustment

    The Social Adjustment Scale-Adolescent version (SAS-SR, 23-item, self-report, 5-point Likert scale, 0-115 range, higher score indicates higher level of social dysfunction).

    Measured: Baseline through 12 months

  24. Systolic and diastolic blood pressure

    Measured in millimeters of mercury.

    Measured: At baseline

  25. Height

    Measure by standard medical office practice measure, without shoes, in centimeters.

    Measured: At baseline

  26. Weight

    Measured in kilograms by standard medical office scale, fully clothed participant.

    Measured: At baseline

  27. Body Mass Index

    Calculated by measuring height (centimeters) and weight (kilogram) to calculate kg/meters squared (BMI, Body Mass Index).

    Measured: At baseline

Secondary outcomes (2)
  1. Moderation of COVID-19-related behaviors and consequences

    The investigators will examine COVID-19-related behaviors and consequences (e.g. social distancing, sheltering-in-place, family illness and death) that that may be moderators of study outcomes using the Holliston at-Home Questionnaire (a 40-item, adolescent self-report, 5-point Likert scale, 0-150 score range, higher score indicates greater behaviors and consequences).

    Measured: Baseline through 12 months

  2. Moderation of COVID-19-related social determinants of health

    The investigators will examine COVID-19-related social determinants of health (e.g. food insecurity, internet access, unemployment) that may be moderators of study outcomes using the Holliston at-Home Questionnaire (a 40-item, adolescent self-report, 5-point Likert scale, 0-150 score range, higher score indicates greater number of social determinants).

    Measured: Baseline through 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jan 2022
  2. Study start1 Feb 2022
  3. Primary completion31 Mar 2026
  4. Study completion31 Oct 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Factorial
Model description
The Multiphase Optimization Strategy (MOST) will be utilized to optimize a primary care, technology-based intervention (CATCH-IT) for the prevention of depression in at-risk adolescents to optimize efficacy, tolerability and scalability for implementation studies and eventual dissemination. This MOST process includes: (1) theoretical organization of components, target behaviors and links to preventive outcomes (vulnerability and protective factors, likelihood of developing depressive episode), (2) selection of components for factorial design, (3) optimization criteria and (4) factorial design (randomization, intervention delivery, assessments, analysis and optimization). The theoretically grounded components selected are: (1) behavioral activation modules; (2) cognitive-behavioral therapy modules; (3) interpersonal psychotherapy modules; and (4) parent program modules.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
400 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05203198
Sponsor's protocol ID
CHAIRb 20080601
Other IDs
1R01MH124723-01, 3R01MH124723-04S1
Acronym
PATHway
Status last verified
Jun 2026
First submitted
10 Jan 2022
Last updated
22 Jun 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Competent Adulthood Transition with Cognitive-Behavioral, Humanistic and Interpersonal Training in people with Depression and Mental Disorder in Adolescence, run by University of Illinois Chicago at 6 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 27 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 22 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 6 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time (time frame: Baseline through 12 months). The study lists 27 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
PATHway Clinical Trial NCT05203198 | AzTrials